Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Agilent Technologies    A

AGILENT TECHNOLOGIES

(A)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths
  • The close medium term support offers good timing for purchasing the stock.
  • The group's high margin levels account for strong profits.
  • The company is in a robust financial situation considering its net cash and margin position.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • Historically, the company has been releasing figures that are above expectations.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
  • With an enterprise value anticipated at 4.2 times the sales for the current fiscal year, the company turns out to be overvalued.
  • The company is not the most generous with respect to shareholders' compensation.
Ratings chart
Sector Advanced Medical Equipment & Technology - NEC
1st jan.Capitalisation (M$)Investor Rating
AGILENT TECHNOLOGIES3.10%21 561
THERMO FISHER SCIENTIFIC20.36%107 872
DANAHER CORPORATION31.30%97 132
BOSTON SCIENTIFIC CORPORATI..20.80%57 349
INTUITIVE SURGICAL1.18%55 850
EDWARDS LIFESCIENCES CORPOR..38.43%44 098
ROYAL PHILIPS34.93%41 845
ILLUMINA, INC.-3.78%41 078
SIEMENS HEALTHINEERS-3.26%39 361
SHENZHEN MINDRAY BIO-MEDL E..--.--%30 057
CERNER CORPORATION36.69%21 629
RESMED19.47%18 990
OLYMPUS CORP-62.88%15 847
WATERS CORPORATION11.31%13 683
HOLOGIC21.29%12 865
CARL ZEISS MEDITEC AG50.51%10 242
More Results
Financials (USD)
Sales 2019 5 123 M
EBIT 2019 1 183 M
Net income 2019 1 102 M
Finance 2019 26,6 M
Yield 2019 0,94%
P/E ratio 2019 19,9x
P/E ratio 2020 23,0x
EV / Sales2019 4,20x
EV / Sales2020 3,89x
Capitalization 21 561 M
Upcoming event on AGILENT TECHNOLOGIES
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes